Can Iron Supplements Cause High Blood Pressure?

Standard oral iron supplements taken at typical doses for iron deficiency do not reliably raise blood pressure in most people. Several short-term studies in healthy adults and middle-aged women have found no significant changes in systolic or diastolic blood pressure during supplementation. But the relationship between iron and blood pressure is far from simple. Higher iron stores in the body are consistently linked to higher blood pressure in large population studies, and in specific groups like non-anemic pregnant women, supplementation has been tied to a meaningfully increased risk of developing hypertension.

Iron Stores and Blood Pressure at the Population Level

The clearest signal connecting iron to blood pressure comes not from supplement trials but from studies measuring ferritin, a protein that reflects how much iron your body has stored. A cross-sectional study of U.S. adults found that people with higher serum ferritin levels were more likely to have elevated systolic and diastolic blood pressure. Those in the upper ranges of ferritin (above roughly 74 and especially above 147 micrograms per liter) had a meaningfully higher odds of hypertension compared to those with lower levels.¹ This does not prove that iron caused the blood pressure increase, since people with higher ferritin also tend to differ in other ways (diet, weight, inflammatory status). But the pattern is consistent across several studies and survived statistical adjustments for many of those confounders.

When researchers look at dietary iron intake rather than blood levels, the picture gets more nuanced. A large nationwide cohort study in China found a U-shaped curve: people with very low and very high total iron intake had the highest rates of developing hypertension, while those in the moderate range had roughly 24% lower risk compared to the lowest intake group.² In other words, too little iron and too much iron both appeared unfavorable for blood pressure. A separate large epidemiological study found that heme iron (the kind from red meat) showed a small positive association with blood pressure, but the differences were modest and largely disappeared after adjusting for other dietary factors.³

The takeaway from population data is that the body’s total iron burden seems to matter more than whether you take a daily pill. Moderate iron intake appears protective, while chronically elevated iron stores track with higher blood pressure. For someone who is genuinely iron-deficient and taking supplements to correct that deficiency, the risk profile looks very different from someone who is already iron-replete and adding more.

How Excess Iron Can Damage Blood Vessels

The biological story behind these population patterns centers on oxidative stress. When iron exists in excess in the bloodstream, it can participate in chemical reactions that generate highly reactive molecules called free radicals. These radicals damage the inner lining of blood vessels and interfere with nitric oxide, a molecule that signals arteries to relax. When nitric oxide is neutralized by oxidative damage, vessels become stiffer and less responsive, which raises the resistance that blood encounters as it flows, pushing pressure upward.⁴

Iron also appears to activate the renin-angiotensin system, one of the body’s main blood pressure control pathways. In animal models of iron overload, iron accumulation in the kidneys led to increased expression of renin, the enzyme that kicks off a hormonal cascade ending in constricted blood vessels and retained sodium.⁵ If this mechanism translates to humans with high iron stores, it would provide a direct hormonal pathway from excess iron to elevated blood pressure, independent of the vascular damage described above.

A third pathway involves the sympathetic nervous system. Patients with hereditary hemochromatosis, a genetic condition causing severe iron overload, had nearly double the sympathetic nerve firing rate compared to healthy controls. After iron-depletion therapy brought their iron levels down, sympathetic nerve activity dropped dramatically and their bodies’ blood pressure reflexes improved significantly.⁶ Heightened sympathetic tone means faster heart rate and constricted blood vessels, both of which push blood pressure up. The fact that this resolved with iron removal strongly suggests the iron itself was driving the nerve overactivity.

Pregnancy and Iron Supplementation

Pregnancy is the context where the connection between iron supplements and blood pressure has been studied most directly, and where the findings are most concerning. Many pregnant women are given iron supplements routinely, sometimes even when they are not anemic. A controlled trial of 400 non-anemic pregnant women found that those who received iron supplements developed new-onset hypertension after 20 weeks at more than double the rate of the control group: about 13.5% versus 6.5%.⁷ That is a relative risk of roughly 2.1, which is substantial for a condition that can threaten both mother and baby.

A meta-analysis pooling results from multiple studies reinforced this pattern, finding that higher serum iron levels were associated with increased risk of hypertensive disorders during pregnancy, including both gestational hypertension and preeclampsia.⁸ The mechanism likely involves the same oxidative and vascular pathways described earlier, but pregnancy amplifies the stakes. The placenta is highly sensitive to oxidative damage, and blood volume and vascular dynamics are already under enormous strain.

This does not mean pregnant women should avoid iron. Those who are actually iron-deficient need supplementation, and untreated anemia during pregnancy carries its own serious risks. The concern is specifically about supplementing women whose iron stores are already adequate. For women who are not anemic, routine iron supplementation in early pregnancy may do more harm than good from a blood pressure standpoint. Checking ferritin before prescribing iron is the simplest way to avoid this problem, though not all prenatal protocols include that step.

Intravenous Iron and Blood Pressure Spikes During Dialysis

People receiving hemodialysis commonly get iron through an IV, and this creates a unique blood pressure scenario. A large study of dialysis patients found that receiving higher doses of intravenous iron sucrose during a dialysis session was associated with a small but consistent rise in blood pressure during treatment. Patients receiving 100 milligrams or more of iron sucrose had about 1.2 mmHg higher lowest systolic blood pressure during dialysis compared to sessions without iron, and they were about 7% more likely to experience intradialytic hypertension.⁹

Interestingly, the same doses also appeared to protect against intradialytic hypotension (blood pressure dropping too low), reducing that risk by about 11%. So the effect of IV iron was essentially to stabilize blood pressure at a slightly higher set point during the session. For most dialysis patients, a 1-2 mmHg shift is not clinically alarming, but it matters for those who already struggle with blood pressure control during treatment. The mechanism is likely related to the rapid delivery of large amounts of free iron into the bloodstream, which can trigger acute oxidative stress and vasoconstriction that oral supplements, absorbed slowly through the gut, would not produce.

What Iron Overload Conditions Reveal

Hereditary hemochromatosis provides a kind of natural experiment in what happens when iron accumulates far beyond normal levels. Patients with this condition showed significantly stiffer arteries than healthy controls, with pulse wave velocity (a direct measure of arterial stiffness) averaging about 8.5 versus 6.4 meters per second. They also showed signs of endothelial dysfunction, and both problems improved after iron removal through regular blood draws.¹⁰

The reversibility is an important detail. It suggests that iron-driven vascular damage is not purely structural. At least some of the stiffening and dysfunction can be undone by lowering iron levels, which implies an ongoing biochemical process (likely the oxidative and inflammatory mechanisms discussed earlier) rather than permanent scarring. For people without hemochromatosis, these findings serve as a warning about what persistent iron excess does to blood vessels over time. They also connect the dots between the sympathetic nerve overactivity observed in the same patient population and the downstream cardiovascular consequences.

When Iron Supplements Lower Blood Pressure

The relationship flips in certain populations, particularly in young children born at low birth weight. A randomized controlled trial found that low-birth-weight infants who received iron supplements (at 1 or 2 milligrams per kilogram of body weight daily) during infancy had lower systolic blood pressure at age seven compared to those who did not receive supplements.¹¹ The researchers noted that children born small are already at elevated risk for developing hypertension later in life, and that correcting early iron deficiency might reduce that trajectory.

This finding makes physiological sense. Iron deficiency itself is not benign for the cardiovascular system. Severe deficiency can cause the heart to work harder (since iron-deficient blood carries less oxygen), it impairs normal vascular development, and in children it may alter how blood pressure regulation is programmed during critical growth windows. Correcting a genuine deficiency removes those stressors, which may explain why supplementing iron-deficient populations tends to either lower blood pressure or leave it unchanged, while adding iron to already-replete populations pushes it in the wrong direction.

The U-shaped curve from the Chinese dietary study fits this pattern neatly. Too little iron is harmful, optimal iron is protective, and excess iron becomes a liability again. The trouble is that many people taking supplements do not know where they fall on that curve.

Iron Supplements and Blood Pressure Medications

Even if iron supplements do not directly raise your blood pressure, they can undermine the medications that control it. Iron is notorious for binding to other drugs in the gut and reducing their absorption. Among the affected medications are methyldopa (used for blood pressure during pregnancy), captopril (an ACE inhibitor), and levodopa, along with tetracycline antibiotics and thyroid hormone.¹² The mechanism is straightforward: iron forms stable chemical complexes with these drugs in the digestive tract, preventing the active drug from being absorbed into the bloodstream.

For someone whose blood pressure is well controlled on captopril or methyldopa, starting an iron supplement without spacing the doses could effectively reduce their medication’s potency, leading to a rise in blood pressure that looks like the iron caused it directly. The standard recommendation is to take iron supplements at least two hours apart from these medications. But in practice, people often take all their pills at once, and the interaction is not always flagged at the pharmacy.

A related concern applies to people already on antihypertensive therapy who take iron habitually. A UK Biobank analysis found that habitual iron supplementation was associated with a roughly 21% higher risk of developing chronic kidney disease specifically in people already using antihypertensive medications. No such association appeared in people with normal blood pressure or in those with high blood pressure who were not on medication.¹³ The researchers speculated that the combination of iron-induced oxidative stress and the altered renal dynamics in treated hypertension might create a particularly vulnerable situation for the kidneys. This is observational data, so causation is not established, but it raises a flag worth noting for long-term supplement users.

Short-Term Supplementation Studies in Healthy People

Given all the concerning signals above, it is worth emphasizing what happens in the most common real-world scenario: a non-pregnant adult taking a standard oral iron supplement for a few weeks or months. The short-term evidence here is largely reassuring. A randomized trial of pregnant women comparing ferrous bisglycinate (a gentler iron formulation) with a control group found no significant differences in blood pressure before or after the intervention.¹⁴ A study examining different doses of iron supplementation in middle-aged women also found no blood pressure differences between groups.¹⁵

These null results make sense when you consider the mechanism. Oral iron is absorbed slowly through the gut, and a healthy body tightly regulates how much it takes in via hepcidin, a hormone that puts the brakes on iron absorption when stores are adequate. For most people, a standard 30-65 milligram elemental iron supplement corrects a deficiency without dramatically overshooting. The problems outlined in this article tend to arise either when iron accumulates over long periods in people who do not need it, when large doses are delivered intravenously, or when underlying conditions (pregnancy, kidney disease, hemochromatosis) alter how the body handles iron.

Practical Considerations for Supplement Users

If you are taking iron because a blood test showed you are deficient, your blood pressure is almost certainly not going to rise as a result. In fact, correcting the deficiency may benefit your cardiovascular system. The concerns kick in under more specific circumstances:

• Non-anemic pregnancy: If you are pregnant and not anemic, ask your provider to check your ferritin before starting iron. Routine supplementation in iron-replete pregnant women has been associated with higher rates of gestational hypertension.
• Long-term supplementation without monitoring: Taking iron for months or years without rechecking your levels can allow stores to creep above the optimal range, particularly in men and postmenopausal women who do not lose iron through menstruation.
• Concurrent blood pressure medications: If you take ACE inhibitors like captopril, or methyldopa, space your iron supplement at least two hours away to avoid reduced drug absorption.
• Kidney disease or dialysis: Intravenous iron delivery during dialysis can cause transient blood pressure rises. This is generally managed by the dialysis team, but report any symptoms of sudden blood pressure elevation during sessions.
• Hemochromatosis or high ferritin: If you have a known iron overload condition or have been told your ferritin is already elevated, iron supplements are likely harmful for your blood vessels and should be avoided unless a specialist says otherwise.

The simplest protective step is also the most frequently skipped: getting a blood test before starting iron supplements and periodically while taking them. Ferritin, serum iron, and transferrin saturation together give a clear picture of whether your body needs more iron or already has enough. Supplements bought over the counter do not require a prescription, which means many people start and continue them based on symptoms like fatigue without ever confirming an actual deficiency. Given that excess iron can silently stiffen arteries, increase oxidative damage, and potentially interfere with blood pressure control, checking your levels is a small effort with outsized returns.